MRI Contraindications and Implants

Why the surgeon is asked. MRI safety in patients with implants is one of the most clinically important topics in musculoskeletal radiology. As MRI use continues to increase and the population of patients with orthopaedic implants grows, orthopaedic surgeons are frequently asked whether their patients can safely undergo MRI. The common version of the question is a patient with a joint replacement who needs MRI of the spine, and a safe answer rests on understanding how implants and the magnetic field interact.

Ferromagnetism, not metal. The interaction between an implant and the magnetic field depends on the ferromagnetic properties of the material, not simply on whether it is metal. Ferromagnetic materials (iron, nickel and cobalt in certain alloys) experience strong forces in the field; non-ferromagnetic metals (titanium, tantalum and most modern orthopaedic alloys) experience minimal forces and are generally safe.

The three safety categories. ASTM International defines three standardised labels, and every device carries one of them:

• MR Safe - poses no hazard in any MR environment: non-metallic, non-conducting, non-magnetic items such as plastic, ceramic and PEEK cages
• MR Conditional - safe under specified conditions documented by the manufacturer (field strength, spatial gradient, SAR limits, body part scanned). Most modern orthopaedic implants are MR Conditional at 1.5T
• MR Unsafe - poses hazards in all MR environments and must not enter the scanner room

The obsolete term "MRI compatible" should no longer be used; the three-tier classification replaced it.

View larger

Missile effect. Translational force pulls a ferromagnetic object toward the scanner bore and can accelerate it to lethal velocity. The force is proportional to the ferromagnetism of the material and to the spatial gradient of the magnetic field.

Torque. A ferromagnetic object experiences a rotational force that tries to align its long axis with B0. This can displace an implant, the traditional concern being the first 6 weeks before tissue ingrowth; how far that concern still applies to modern implants is discussed under Controversies.

Heating. A metallic implant, especially one forming a loop or with a long conductive path, can absorb radiofrequency energy and heat, risking thermal tissue damage.

Artefact. Metal distorts the local magnetic field, producing signal void, signal pile-up and geometric distortion that can render images non-diagnostic. Reducing it is the subject of its own section below.

Cardiac pacemakers and defibrillators. This is the most critical MRI safety scenario. A non-MR-conditional pacemaker or implantable cardioverter-defibrillator (ICD) is an absolute contraindication. The potential harms:

• Lead heating causing myocardial thermal injury
• Induced electrical currents causing inappropriate pacing or defibrillation
• Device malfunction, reset or permanent damage
• Lead tip displacement due to electromagnetic forces

MR-conditional cardiac devices. Modern MR-conditional pacemakers, available since approximately 2011, can be scanned under strict conditions:

• A specific field strength only (usually 1.5T only)
• Specific SAR limits
• Reprogramming to MR mode before scanning and restoration afterward
• Cardiology supervision with continuous monitoring

The orthopaedic relevance. Patients with cardiac devices frequently require MRI for orthopaedic conditions of the spine, shoulder and hip. Check the device type, consult cardiology, and consider alternative imaging if the device is MR Unsafe. Never bypass the screening process.

Ferromagnetic intracranial aneurysm clips can torque and displace in the magnetic field, causing fatal intracranial haemorrhage.

Cochlear implants. Older cochlear implants are MR Unsafe; newer models may be MR Conditional. Always verify with the manufacturer.

Intraocular metallic foreign body. Metallic fragments in the eye, for example from grinding, can move and cause retinal damage. Orbital radiograph screening is required if the history suggests the risk.

Other electronic devices. Many neurostimulators, insulin pumps and drug infusion devices are MR Unsafe unless specifically certified as MR Conditional.

View larger

View larger

View larger

View larger

Beyond implants and devices, the other major MRI contraindication the surgeon must know concerns gadolinium-based contrast agents (GBCAs).

Nephrogenic systemic fibrosis (NSF) is a rare but serious scleroderma-like fibrosing disorder of skin, joints and viscera linked to GBCAs in patients with severe renal impairment: eGFR below 30 mL/min/1.73m², dialysis, or acute kidney injury. Screen renal function (eGFR) before giving contrast to at-risk patients.

Agent classes. In the ACR scheme the older Group I (linear) agents carry the highest NSF risk and are largely withdrawn or restricted; Group II (macrocyclic) agents have a very low or negligible NSF risk and are now preferred. With appropriate agent selection and renal screening, NSF is now very rare.

Retention and deposition. Trace gadolinium can deposit in the brain (dentate nucleus, globus pallidus) and bone, more with linear agents. The clinical significance is uncertain, but it favours using the lowest effective dose of a Group II agent.

Hypersensitivity and pregnancy. Acute hypersensitivity reactions are uncommon but possible, from urticaria to anaphylaxis, so ask about any prior contrast reaction. Gadolinium crosses the placenta and is avoided in pregnancy unless essential; non-contrast MRI itself is generally considered safe in pregnancy when indicated.

View larger

View larger

The screening framework. The same six steps apply to every patient with a possible implant, and an implant that cannot be identified is assumed MR Unsafe unless the clinical need is urgent and the risk-benefit ratio favours scanning.

The MRI environment: the ACR safety zones. Screening is enforced physically through the ACR four-zone access-control model. The magnet is always on, so access is controlled by location rather than by switching the field off, and the zones escalate control as the magnet is approached.

View larger

View larger

Titanium. Titanium alloy (Ti-6Al-4V) is the preferred material where MRI is likely to be needed later. It is non-ferromagnetic, so there is no missile or torque risk; it produces minimal susceptibility artefact, so diagnostic imaging near the implant is possible; it is MR Conditional at 1.5T and on many 3T scanners; and it is biocompatible with excellent osseointegration. Its limitation is that it cannot be used for bearing surfaces, because its wear characteristics for articulation are poor.

View larger

View larger

Spin echo, not gradient echo. Spin echo sequences use a 180-degree refocusing pulse that partly corrects field inhomogeneities; gradient echo has no refocusing pulse and produces much more artefact. Fast spin echo is the preferred form.

Wider receiver bandwidth reduces the size of the susceptibility artefact, the geometric distortion, at the cost of increased noise.

STIR rather than chemical fat saturation. STIR, used for fluid and oedema detection, is based on T1 relaxation rather than frequency, so it works near frequency-shifted metal where chemical fat saturation does not.

Smaller voxels. Thinner slices and a higher matrix reduce intravoxel dephasing.

Dedicated sequences. MAVRIC-SL and SEMAC are dedicated metal artefact reduction sequences that use multi-spectral imaging and slice-encoding corrections to dramatically reduce artefact.

Field strength. Scanning at 1.5T instead of 3T halves susceptibility artefact, and the rule of thumb that artefact roughly scales with field strength favours 1.5T for large implants. But 3T is not universally inferior near metal: it offers higher signal-to-noise, and with modern multispectral sequences and high bandwidth, diagnostic imaging around smaller implants (screws, anchors, fine wires) at 3T is often acceptable. The field-strength choice should be individualised to implant size, alloy and the clinical question rather than applied as an absolute.

View larger

View larger

MRI safety is governed worldwide by a consistent framework — standardised ASTM International terminology (MR Safe / MR Conditional / MR Unsafe), the four-zone access-control model, and mandatory pre-scan screening — but the implementing society and the local infrastructure vary by region. Demand is rising globally as both MRI utilisation and the prevalence of orthopaedic implants increase with ageing populations.

Side-by-Side Guidance

Registries and Implant Identification

When the operative note or implant card is missing, national arthroplasty registries can help identify the device and therefore its alloy and MR labelling. Large registries include the National Joint Registry (NJR, UK), the American Joint Replacement Registry (AJRR, US), the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), and the Swedish and Norwegian registries. Manufacturer databases and curated resources such as MRIsafety.com complement these for non-arthroplasty hardware.

High- vs Limited-Resource Practice Variation

In well-resourced centres, 1.5T and 3T scanners, dedicated metal-artefact-reduction sequences (MAVRIC, SEMAC, WARP, MARS), ferromagnetic detection systems, and formal MR safety officer roles are routine. In limited-resource settings, access to MRI itself may be restricted, advanced metal-suppression sequences may be unavailable, and implant identification can be difficult where surgical records or registries are incomplete. Where MRI capacity is constrained, CT (with metal-artefact-reduction reconstruction), ultrasound, and radiographs carry more of the diagnostic load, and rigorous screening discipline becomes even more important because rescue resources are limited.

The Surgeon's Responsibilities (Universal)

Regardless of region, the operating surgeon should: accurately document the implant manufacturer, model, and material in the operative record; provide the patient with an implant identification card; and communicate implant details to radiology whenever MRI is being considered.

The 6-week post-implantation wait. The traditional teaching that MRI should be delayed for 6 weeks after implantation, to allow tissue ingrowth to resist torque, is largely historical: it applied to a concern about ferromagnetic implant migration. For modern non-ferromagnetic titanium and cobalt-chrome implants, translational force and torque are minimal, there is little evidence that early scanning displaces a well-fixed implant, and the wait is no longer considered necessary if the clinical need is urgent. Most authorities now permit earlier scanning of MR Conditional non-ferromagnetic implants when clinically indicated, while still exercising caution with any genuinely ferromagnetic device.

Scanning non-MR-conditional cardiac devices. A major shift over the past decade is the recognition that many legacy (non-MR-conditional) pacemakers and defibrillators can be scanned at 1.5T under a strict institutional protocol with electrophysiology supervision, device interrogation and reprogramming, and this is now reflected in some cardiology society guidance. It remains an off-label, protocol-driven decision rather than a green light, and the safest answer is still to treat a non-MR-conditional device as a contraindication unless a formal pathway with cardiology is in place.

Tattoo and cosmetic pigment heating. Some tattoo and permanent-makeup pigments contain iron oxide and can cause local heating or a tingling sensation, occasionally a superficial burn. This is usually a minor, self-limiting issue rather than a contraindication: patients should be counselled, monitored and given a means to alert staff, and large or recently applied tattoos near the region of interest warrant extra caution.